Demonstrating its commitment to science advocacy and sustainability, Integrated DNA Technologies (IDT), is now inviting applications for its 2017 Sustainability Award program with a prize pool of more than $50,000
Whilst still in its infancy, 3D Cell Culture is rapidly growing with not only a widespread reach that can be seen across a number of different fields such as 3D bioprinting and microfluidics. The 2nd annual conference will explore these overlapping areas and will also update delegates on developments in surrounding topics such as disease models, organoids, organ-on-a-chip technologies and iPSC advances.
Dassault Systèmes has outlined multiple milestones in its Living Heart Project aimed to drive the creation and use of simulated 3D personalised hearts in the treatment, diagnosis and prevention of heart diseases
The two Startup companies have been recognised by the Pistoia Alliance for their work accelerating research into precision cancer therapies and advancing deep learning in healthcare.
A new collaboration featuring a prestigious line-up of pharma companies, academic organisations and SMEs are aiming to improve the security in the drug development process
Elsevier has announced it is donating its Unified Data Model (UDM) to The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences research.
Certara, a provider of software for in model-informed drug development and regulatory science, has announced the launch of Phoenix 8.0
The Australian Institute of Marine Science (AIMS) has chosen the Matrix Gemini Laboratory Information Management System (LIMS) from Autoscribe Informatics to monitor workflow across its three operations sites
A survey carried out by Elsevier’s Reaxys team found that chemists may need to gain more experience with emerging technologies to help drive innovation and career progression within the field of chemistry
After 6 years of growth, Imanova has been acquired by Invicro to establish a unique imaging and data management company, providing comprehensive services in support of drug development and disease research
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
